Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -120,183 | -82,383 | -42,434 | -34,030 | -23,068 |
| Depreciation Amortization | 8,750 | 5,826 | 2,910 | 13,185 | 9,903 |
| Accounts receivable | 1,018 | 1,276 | 1,976 | -3,291 | -1,307 |
| Accounts payable and accrued liabilities | 654 | -1,026 | -131 | 1,336 | 2,023 |
| Other Working Capital | -8,695 | -9,468 | -6,565 | -9,681 | 1,836 |
| Other Operating Activity | 17,025 | 13,974 | 8,835 | -75,078 | -83,055 |
| Operating Cash Flow | $-101,431 | $-71,801 | $-35,409 | $-107,559 | $-93,668 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -960 | -920 | -235 | -465 | -465 |
| Other Investing Activity | 0 | 0 | 0 | 103,387 | 103,387 |
| Investing Cash Flow | $-960 | $-920 | $-235 | $102,922 | $102,922 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,795 | N/A | N/A | N/A | 0 |
| Common Stock Issued | 20,633 | 6,181 | 4,380 | 2,989 | 241 |
| Common Stock Repurchased | 0 | N/A | N/A | -230 | -230 |
| Other Financing Activity | 117,828 | 0 | 0 | 0 | 2,378 |
| Financing Cash Flow | $127,666 | $6,181 | $4,380 | $2,759 | $2,389 |
| Exchange Rate Effect | -906 | -596 | -188 | -1,287 | -303 |
| Beginning Cash Position | 248,107 | 248,107 | 248,107 | 251,272 | 251,272 |
| End Cash Position | 272,476 | 180,971 | 216,655 | 248,107 | 262,612 |
| Net Cash Flow | $24,369 | $-67,136 | $-31,452 | $-3,165 | $11,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,431 | -71,801 | -35,409 | -107,559 | -93,668 |
| Capital Expenditure | -960 | -920 | -235 | -465 | -465 |
| Free Cash Flow | -102,391 | -72,721 | -35,644 | -108,024 | -94,133 |